Published in Hepatitis Weekly, November 10th, 1997
Researchers concluded that interferon treatment should not be given to hepatitis B surface antigen healthy carriers with normal alanine aminotransferase, regardless of the presence of chronic hepatitis or serum DNA.
There are two distinct phases of chronic hepatitis B virus (HBV) infection. In the first years of the infection, high replication levels of HBV are detected, with serum hepatitis B e antigen (HBeAg) and HBV DNA and a progressive liver disease. Either spontaneously, in about 25 percent of patients per...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly